financetom
Business
financetom
/
Business
/
Intel Unusual Options Activity For August 26
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intel Unusual Options Activity For August 26
Aug 29, 2024 8:51 AM

Whales with a lot of money to spend have taken a noticeably bearish stance on Intel ( INTC ).

Looking at options history for Intel ( INTC ) we detected 27 trades.

If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 55% with bearish.

From the overall spotted trades, 5 are puts, for a total amount of $231,495 and 22, calls, for a total amount of $2,253,673.

What's The Price Target?

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $55.0 for Intel ( INTC ) over the recent three months.

Volume & Open Interest Trends

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Intel's ( INTC ) options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Intel's ( INTC ) substantial trades, within a strike price spectrum from $10.0 to $55.0 over the preceding 30 days.

Intel Option Volume And Open Interest Over Last 30 Days

Noteworthy Options Activity:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
INTC CALL SWEEP NEUTRAL 11/15/24 $1.42 $1.4 $1.41 $22.00 $282.0K 23.2K 9.0K
INTC CALL TRADE BULLISH 11/15/24 $1.41 $1.4 $1.41 $22.00 $259.4K 23.2K 6.9K
INTC CALL SWEEP BULLISH 01/16/26 $11.6 $11.5 $11.6 $10.00 $231.9K 379 200
INTC CALL SWEEP BEARISH 01/16/26 $11.5 $10.4 $11.4 $10.00 $225.7K 379 801
INTC CALL SWEEP BULLISH 11/15/24 $1.41 $1.4 $1.41 $22.00 $204.7K 23.2K 10.5K

About Intel

Intel ( INTC ) is a leading digital chipmaker, focused on the design and manufacturing of microprocessors for the global personal computer and data center markets. Intel ( INTC ) pioneered the x86 architecture for microprocessors and was the prime proponent of Moore's law for advances in semiconductor manufacturing. Intel ( INTC ) remains the market share leader in central processing units in both the PC and server end markets. Intel ( INTC ) has also been expanding into new adjacencies, such as communications infrastructure, automotive, and the Internet of Things. Further, Intel ( INTC ) expects to leverage its chip manufacturing capabilities into an outsourced foundry model where it constructs chips for others.

Having examined the options trading patterns of Intel ( INTC ), our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

Intel's Current Market Status

With a trading volume of 18,269,147, the price of INTC is down by -2.03%, reaching $20.12.

Current RSI values indicate that the stock is is currently neutral between overbought and oversold.

Next earnings report is scheduled for 59 days from now.

Professional Analyst Ratings for Intel

A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $27.0.

An analyst from Cantor Fitzgerald persists with their Neutral rating on Intel ( INTC ), maintaining a target price of $27.

Consistent in their evaluation, an analyst from Truist Securities keeps a Hold rating on Intel ( INTC ) with a target price of $25.

Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on Intel ( INTC ) with a target price of $32.

Consistent in their evaluation, an analyst from Susquehanna keeps a Neutral rating on Intel ( INTC ) with a target price of $26.

Maintaining their stance, an analyst from Morgan Stanley continues to hold a Equal-Weight rating for Intel ( INTC ), targeting a price of $25.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Intel ( INTC ), Benzinga Pro gives you real-time options trades alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EcoSynthetix May Buy Back Up To Near 10% of Its Outstanding Shares
EcoSynthetix May Buy Back Up To Near 10% of Its Outstanding Shares
May 13, 2024
08:45 AM EDT, 05/13/2024 (MT Newswires) -- EcoSynthetix ( ECSNF ) on Monday said it intends to commence a normal course issuer bid. The renewable chemicals company may repurchase up to a maximum of near 4 million shares, or 10% of its outstanding shares, from May 15, 2024, for one year. Under its previous bid, which expired on May 1,...
Booking Designated as a Gatekeeper Under EU Digital Markets Act
Booking Designated as a Gatekeeper Under EU Digital Markets Act
May 13, 2024
08:46 AM EDT, 05/13/2024 (MT Newswires) -- Booking Holdings ( BKNG ) has been designated by the European Commission as a gatekeeper under the Digital Markets Act (DMA), the Commission said Monday. As a result, Booking has six months to submit a detailed compliance report outlining how it complies with each of the DMA's obligations, the Commission said. If Booking...
Market Chatter: Novo Nordisk Plans First Bond Sale in 2 Years
Market Chatter: Novo Nordisk Plans First Bond Sale in 2 Years
May 13, 2024
08:47 AM EDT, 05/13/2024 (MT Newswires) -- Novo Nordisk A/S ( NVO ) , through its finance subsidiary in the Netherlands, has hired banks to help it issue euro-nominated bonds in a benchmark offering with 2- to 10-year maturities, Bloomberg reported, citing a person familiar with the matter. Proceeds would be used for general corporate purposes, including financing its Catalent...
Fulcrum Therapeutics, Sanofi Sign Licensing Deal for Facioscapulohumeral Muscular Dystrophy Treatment
Fulcrum Therapeutics, Sanofi Sign Licensing Deal for Facioscapulohumeral Muscular Dystrophy Treatment
May 13, 2024
08:45 AM EDT, 05/13/2024 (MT Newswires) -- Fulcrum Therapeutics ( FULC ) said Monday it has signed a deal with Sanofi ( SNY ) for losmapimod in treating facioscapulohumeral muscular dystrophy (FSHD). Under the terms of the deal, Sanofi ( SNY ) will have exclusive rights to commercialize losmapimod outside the US, while Fulcrum retains US rights, Fulcrum said. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved